These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38519828)

  • 41. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA; Cej A; Jonas JB
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A microparticle/hydrogel combination drug-delivery system for sustained release of retinoids.
    Gao SQ; Maeda T; Okano K; Palczewski K
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6314-23. PubMed ID: 22918645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Bioadhesive Nanoparticle-Hydrogel Hybrid System for Localized Antimicrobial Drug Delivery.
    Zhang Y; Zhang J; Chen M; Gong H; Thamphiwatana S; Eckmann L; Gao W; Zhang L
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):18367-74. PubMed ID: 27352845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel.
    Feng S; Chen H; Liu Y; Huang Z; Sun X; Zhou L; Lu X; Gao Q
    Sci Rep; 2013; 3():1838. PubMed ID: 23670585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rabbit study of an in situ forming hydrogel vitreous substitute.
    Swindle-Reilly KE; Shah M; Hamilton PD; Eskin TA; Kaushal S; Ravi N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4840-6. PubMed ID: 19324846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
    Yang C; Jiang L; Bu S; Zhang L; Xie X; Zeng Q; Zhu D; Zheng Y
    J Biomed Nanotechnol; 2013 Sep; 9(9):1617-23. PubMed ID: 23980509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of pH-responsive compounds synthesized from chitosan and hyaluronic acid on dual-responsive (pH/temperature) hydrogel drug delivery systems of Cortex Moutan.
    Chatterjee S; Hui PC; Siu WS; Kan CW; Leung PC; Wanxue C; Chiou JC
    Int J Biol Macromol; 2021 Jan; 168():163-174. PubMed ID: 33309656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
    Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
    Sabzevari A; Adibkia K; Hashemi H; Hedayatfar A; Mohsenzadeh N; Atyabi F; Ghahremani MH; Dinarvand R
    Eur J Pharm Biopharm; 2013 May; 84(1):63-71. PubMed ID: 23295645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery.
    Shareef Khan M; Rao Ravi P; Shrikant Dhavan D
    Int J Pharm; 2023 Nov; 647():123530. PubMed ID: 37858638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract.
    Srinivasarao DA; Reddy SS; Reddy GB; Katti DS
    Int J Pharm; 2019 Sep; 568():118474. PubMed ID: 31279055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
    Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained delivery of triamcinolone acetonide from a thermosensitive microemulsion gel system for the treatment of sensorineural hearing loss.
    Nguyen TN; Yoo SY; Tangchang W; Lee JY; Son HY; Park JS
    Drug Deliv; 2023 Dec; 30(1):2242003. PubMed ID: 37537864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide.
    Sheshala R; Hong GC; Yee WP; Meka VS; Thakur RRS
    Drug Deliv Transl Res; 2019 Apr; 9(2):534-542. PubMed ID: 29484530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies.
    Kapadia R; Parikh K; Jain M; Sawant K
    Drug Deliv Transl Res; 2021 Jun; 11(3):984-999. PubMed ID: 32567039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye.
    Roy G; Garg P; Venuganti VVK
    Int J Pharm; 2022 Jan; 612():121305. PubMed ID: 34800618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye.
    Wu Y; Vora LK; Wang Y; Adrianto MF; Tekko IA; Waite D; Donnelly RF; Thakur RRS
    Eur J Pharm Biopharm; 2021 Aug; 165():306-318. PubMed ID: 34048879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.